The Future of Transfusion Medicine at UnityPoint Health

Similar documents
Global Lab for Innovation

Blood System Inventory Management Best Practices Guide

Red blood cell transfusions in the Netherlands Towards (very) low use

BLOOD BANK ANNUAL STATISTICS (HOSPITALS)

STANDARD BLOOD PRODUCTS AND SERVICES

Global Database on Blood Safety

FDA Considerations Regarding Frequent Plasma Collection Procedures

The Blood Budget: how can we reduce costs and influence best practice? Sue Redfearn Blood Transfusion Manager Poole Hospital NHS Foundation Trust

Aktuelle Literatur aus der Notfallmedizin

The 2011 National Blood Collection and Utilization Survey Report

Department of Transfusion Medicine and Immunohematology

Mark Yazer, MD FRCPC. The Institute For Transfusion Medicine Department of Pathology, University of Pittsburgh

Role of the Medical Director

Yvette Marie Miller, M.D. Executive Medical Officer American Red Cross October 20, th Annual Great Lakes Cancer Nursing Conference Troy, MI

Patient Blood Management Guidelines: Module 4. Critical Care

Navigating the Regulatory Issues of Blood Management

Case Study: Using Predictive Analytics to Reduce Sepsis Mortality

Data Management. Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota

Clinical Practice Guidelines for Blood Transfusions

To assist clinicians in the management of minor, major, and/or life-threatening bleeding in patients receiving new oral anticoagulants (NOACs).

- Lessons from SHOT Haemorrhage cases

Hydroxyurea Treatment for Sickle Cell Disease

DRAFT. Medical School Health IT Curriculum Topics. Matthew Swedlund, John Beasley, Erkin Otles, Eneida Mendonca

Business Continuity Plan in Action Alison Turner General Manager National Blood Authority. 28 Feb 2008

BUILDING AND SUSTAINING A BLOOD MANAGEMENT PROGRAM

October 8-9, 2015 AAHP Fall Seminar A SCORING SYSTEM IN THE EMR TO FACILITATE PHARMACIST MONITORING OF ANTICOAGULANTS

Texas Newborn Screening Performance Measures Project

Sample Consent. Transfusion of Prematures (TOP)

TRANSFUSION MEDICINE

Suggestions for Optimizing Use of Plasma in the Era of TRALI Risk Reduction

Donor Adverse Events

Improving Outcomes and Saving Lives in Real Time: How Hospitals Can Use Predictive Analytics Across the Care Continuum Essential Hospitals Engagement

Department of Health - Research Governance Framework (RGF)

Building a Better Patient Blood Management Program

Frequently Asked Questions

Approaches to Asthma Management:

XV.Quality Assurance in the Blood Bank

Southern California Patient Safety First Collaborative Long Beach Memorial Medical Center Team Presentation. September 17, 2014

The Paperless Project - A Practical Paper

Understanding Diseases and Treatments with Canadian Real-world Evidence

SICKLE CELL SCREENING AND SELECT TOPICS IN PREVENTION OF COMPLICATIONS Mark Schuster, M.D., Ph.D.

LABORATORY PROCEDURE MANUAL

Improving Care for Chronic Obstructive Pulmonary Disease (COPD) Coalition Grant Program PROJECT OVERVIEW & RECOMMENDATIONS

COMMUNICATING RADIATION RISKS IN PAEDIATRIC IMAGING

2012 Complex Case Management Program Evaluation

APPLICATION FOR LICENSURE OF A BLOOD BANK (Under the Provisions of N.J.S.A. 26:2A et seq.)

MS-TRIP 2: Disseminating the PPRNet Model for Improving Medication Safety

Evaluating Your Hospitalist Program: Key Questions and Considerations

Duke University Health System Electronic Health Record Update. Art Glasgow Chief Information Officer, Duke Medicine

DVT/PE Management with Rivaroxaban (Xarelto)

Maintaining our momentum in public health. Linda Hindle, Lead AHP, National Engagement Lead for Fire and Police Services

Differentiation = Making specialized cells. Your body needs stem cells. What is a stem cell?

Engage. Connecting with your community to improve population health outcomes. Key Benefits. Orion Health Engage 1

Toolkit: Designing and Implementing a Targeted Outreach Campaign for At-Risk Students

Directed, Autologous and Therapeutic Donations

Main Section of the Proposal

Emerging Benefits of EMR Use in Community-Based Settings

Technology and Analytics Roadmap Positioning for the Future

Cellular Therapy Liaison Meeting 10 September 2009 BECS. M. Allene Carr-Greer, MT(ASCP)SBB Director, Regulatory Affairs AABB

Information for patients needing irradiated blood

Transfusion Medicine

ADMINISTRATIVE MANUAL Policy and Procedure

AUTOLOGOUS BLOOD DONATION

Ten for Patient Safety: Healthcare Optimization in Ontario. April 15 th 1:00PM to 2:00PM Session 173

Obstetrics and Maternity

How does your EHR tie into Patient Safety?

HIMSS Davies Enterprise Application --- COVER PAGE ---

EHRs Are Not Enough: Why HIE Connectivity Matters for PMCH

BLOOD TRANSFUSION SAFETY

Implementation of the ABCDE Bundle: Results from a Real-World, Pragmatic Study Design. Andrew Masica, MD, MSCI Chief Clinical Effectiveness Officer

Sanford Improvement Making Lean Work in Healthcare

Action Plan Checklist

31.5% Would Estimate Accountable Care Organizations Currently Have a Material Impact in Their Marketplace

Getting Ready for Patient Blood Management Certification. Steve Frank, MD Eduardo Nunes, MPP, CAE Stacy Olea, MT(ASCP), FACHE May 12, 2016

Telemedicine Resuscitation & Arrest Trials (TreAT)

Recommendations: Other Supportive Therapy of Severe Sepsis*

Pan-Canadian Nursing Electronic Health Record (EHR)Business and Functional Elements to Support Clinical Practice

Menu Item: Dashboards and Analytics/Business Informatics

Department of Behavioral Sciences and Health Education

Mississippi Delta Health Collaborative Mississippi State Department of Health 1

Computer Decision Support for Antimicrobial Prescribing: Form Follows Function. Matthew Samore, MD University of Utah

The A1C Test and Diabetes

MLT 118L Clinical Immunology/Immunohematology Lab

Analytic-Driven Quality Keys Success in Risk-Based Contracts. Ross Gustafson, Vice President Allina Performance Resources, Health Catalyst

UCSF. Analytics Strategies, Processes & Technologies: Synergistic Partnerships that Improve Care and Operations Years of IT Collaboration

Contribute to resource plan development in contact centre operations

The NIH Roadmap: Re-Engineering the Clinical Research Enterprise

Change Management for Health IT: Preparing for your Next Challenge

Promoting Health Information Exchange at the State Level in Florida Thursday, March 5, 2009 Bethesda, MD

Health Service Circular

MEASURING PATIENT SATISFACTION IN UCMB HEALTH INSTITUTIONS

Laboratory Quality Metrics

HCA ETHICS AND COMPLIANCE PROGRAM

BLOOD BANK SPECIMEN COLLECTION PROCEDURE

Population Health Solutions for Employers MEDIA RESOURCES

ICD-10 Strategy How to Operationalize in a Hospital Environment. HFMA Region 11 Healthcare Symposium January 21, 2014

V: Infusion Therapy. Alberta Licensed Practical Nurses Competency Profile 217

How To Be A Community Based Health Advisor

Diagnostic Tests. Brad Spring Director, Regulatory Affairs

Dabigatran (Pradaxa) Guidelines

Transcription:

The Future of Transfusion Medicine at UnityPoint Health Carol Collingsworth, MBA, MT(ASCP)SC Director, Laboratory Management UnityPoint Health St. Luke s, Cedar Rapids Who are we? 2 1

Sustainability A Key System Strategy UnityPoint Health s (UPH) Laboratory Affinity Group has identified Patient Blood Management (PBM) as one of four critical initiatives to improve the quality and safety of patient care PBM has grown in interest due to concerns with: The increasing known and unknown risks of blood transfusion The rising cost of a limited resource Recent clinical trials have shown: Hemodynamically stable patients can tolerate lower Hemoglobin levels than previously thought, without any additional adverse affects Patients may have reduced morbidity and mortality with a restrictive transfusion practice Lab Affinity Group s PBM Goals Preventing unnecessary blood transfusions Assuring the transfusion of The right product At the right time In the right dose To the right patient A PBM Task Force was created in 4 th QTR 2012 to: Harmonize transfusion guidelines Support performance improvement by promoting best blood management practices 2

Initial Interventions Efforts to date have included: Analyzing Red Blood Cell (RBC) utilization by affiliate, service line, provider and patient risk Adopting the American Association of Blood Banks (AABB) evidence-based RBC transfusion guidelines (e.g. recommends adhering to a restrictive transfusion strategy (7-8 g/dl target) in hospitalized, stable patients) Disseminating educational materials (PBM White Paper and posters) Implementing Epic transfusion ordering decision support (Best Practice Alert [BPA]) Encouraging one transfusion at a time ( One and Done Campaign) Development of a UPH RBC Management toolkit has enabled tracking of key data, pre- and postimplementation of the Epic BPA in March 2014 Initial Interventions Best Practice Alerts 3

Initial Interventions Best Practice Alerts Initial Interventions Best Practice Alerts 4

Initial Interventions One and Done Education Findings to Date - Overall UPH Includes all ordering providers, Performance all APRDRGs, and all service lines Reflects Expected vs. Actual % of Inpatients (IP) Transfused Expected = % expected to be transfused based upon prior three month s data, modeled to adjust for case mix and severity of illness Actual = Actual % transfused Actual % IP transfused has decreased from 9.7% in Q2-12 to 8.1% in Q4-14 Reflects a 16.5% overall decrease in % IP Transfused 5

Findings to Date Overall UPH July 2013 March Performance 2014 April 2014 Dec 2014 Pre BPA RBC Units per Transfusion One unit = 50.19% Two unit = 47.34% Post BPA RBC Units per Transfusion One unit = 54.06% Two unit = 43.89% 7.7% increase in one unit transfusions 7.3% decrease in two unit transfusions Findings to Date Overall UPH July 2013 March Performance 2014 April 2014 Dec 2014 Pre BPA Transfusions by Hb Level Transfused at Hb 6-7 = 13.64% Transfused at Hb 7-8 = 42.77% Transfused at Hb 8-9 = 28.48% Post BPA Transfusions by Hb Level Transfused at Hb 6-7 = 20.15% Transfused at Hb 7-8 = 44.17% Transfused at Hb 8-9 = 21.14% 47.7% increase in transfusions at Hb 6-7 25.8% decrease in transfusions at Hb 8-9 6

Findings to Date Cedar Rapids Region July 2013 March 2014 April 2014 Dec 2014 Pre BPA RBC Units per Transfusion One unit = 56.56% Two unit = 41.45% Post BPA RBC Units per Transfusion One unit = 67.65% Two unit = 30.67% 16.4% increase in one unit transfusions 26.0% decrease in two unit transfusions Findings to Date Cedar Rapids Region July 2013 March 2014 April 2014 Dec 2014 Pre BPA Transfusions by Hb Level Transfused at Hb 6-7 = 9.77% Transfused at Hb 7-8 = 38.19% Transfused at Hb 8-9 = 27.87% Post BPA Transfusions by Hb Level Transfused at Hb 6-7 = 18.84% Transfused at Hb 7-8 = 37.87% Transfused at Hb 8-9 = 20.12% 48.1% increase in transfusions at Hb 6-7 27.8% decrease in transfusions at Hb 8-9 7

Findings to Date Cedar Rapids Region One and Done Campaign Initiated in August 2014 Lessons Learned Implementation across all regions of UPH presented some barriers, including: Working with multiple medical staffs at each affiliate required variations in approach Identifying a central medical staff contact for distribution of educational materials Identifying IT and analytics resources to support development of BPAs and collection / tracking of results Driving practice change at the physician level via performance metrics Elevating IT and data collection needs to drive timely outcomes 8

Lessons Learned A final outcome to note: Although we are transfusing a smaller % of inpatients, we have seen a slight increase in our average # RBC units transfused (Q4-14 expected = 2.75 vs. Q4-14 actual = 2.84) This may be attributed to providers allowing patients to reach a lower hemoglobin level before transfusing, but then transfusing greater than one unit per transfusion to bring the hemoglobin level up to desired levels will continue to track moving forward Critical Success Factors Factors to consider in your PBM journey: Recruit strong physician champions Base decisions on evidence based criteria Ensure timely and clear communication / education Recruit IT and analytics colleagues early on to enable timely development of decision support and analytics tools Develop ways to share results with all key stakeholders to drive change Celebrate success! 9

Next Steps Future PBM initiatives will include: Finalizing the RBC Epic order set to include clear transfusion indications Starting to develop usage guidelines for platelets, fresh frozen plasma and cryoprecipitate Appreciate the opportunity to share! Thank you! 10